Efficacy of Extracorporeal Shockwave Therapy on Painful Bone Spur in Traumatic Transfemoral Amputees: A Randomized Controlled Trial
Traumatic Transfemoral Amputation · Painful Bone Spur
Enrolment: 29 · Results not recorded
Loading the evidence…
Device
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Traumatic Transfemoral Amputation · Painful Bone Spur
Enrolment: 29 · Results not recorded
Knee Osteoarthritis
Enrolment: 120 · Results not recorded
Adhesive Capsulitis
Enrolment: 65 · Results not recorded
Hemiplegic Cerebral Palsy
Enrolment: 45 · Results not recorded
Peyronie Disease
Enrolment: 50 · Results not recorded
Fibromyalgia · Myofascial Pain Syndrome · Central Sensitization
Enrolment: 40 · Results not recorded
Insertional Achilles Tendinopathy
Enrolment: 30 · Results not recorded
Cerebral Palsy, Spastic
Enrolment: 40 · Results not recorded
2 studies reported at therapy level; 2 evidence entries itemised.
Model: ischaemic epigastric skin flap
ESWT improved flap perfusion, microvessel number and survival through neovascularisation irrespective of application timing.
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.
Model: Cardiotoxin-induced acute injury of the quadriceps femoris muscle
Regenerating fibre size and myonuclear content were significantly greater in shock wave treated muscle at both 4 and 7 days, with higher satellite cell content and myogenic regulatory factor expression. Mitotic activity at 4 days was doubled compared with untreated injured muscle.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.